programma definitivo - SocietÃ italiana di neurologia

More documents

Recommendations

Info

3 N O V E M B R E • A R E A P O S T E R 140. MXA MRNA QUANTIFICATION ALLOWS THE PREDICTION OF DISABILITY PROGRESSION IN IFNß-TREATED MULTIPLE SCLEROSIS PATIENTS F. SERANA, L. IMBERTI, M. AMATO, G. COMI, C. GASPERINI, L. PROVINCIALI, M. ROTTOLI, S. SOTGIU, S. STECCHI, M. VECCHIO, M. ZAFFARONI, R. CAPRA (Brescia, Firenze, Milano, Roma, Ancona, Bergamo, Sassari, Bologna, Caltanisetta, Gallarate - VA, Montichiari - BS) 141. ADULT-ONSET AGAINST PEDIATRIC-ONSET MULTIPLE SCLEROSIS: DIFFERENCES IN MRI TISSUE DAMAGE F. ROSSI, M. BATTAGLINI, M. STROMILLO, A. GIORGIO, M. MORTILLA, E. PORTACCIO, B. HAKIKI, M. AMATO, N. DE STEFANO (Siena, Firenze) 142. SAFETY OF THE FIRST DOSE OF FINGOLIMOD FOR MULTIPLE SCLEROSIS: RESULTS OF AN OPEN-LABEL CLINICAL TRIAL A. LARONI, D. BROGI, V. BRESCIA MORRA, L. GUIDI, C. POZZILLI, G. COMI, A. LUGARESI, R. TURRINI, D. RAIMONDI, A. UCCELLI, G. MANCARDI (Genova, Napoli, Empoli, Roma, Milano, Chieti, Origgio - VA) 143. FINGOLIMOD IN REAL CLINICAL PRACTICE - A SECOND LINE TREATMENT D. BARONCINI, A. GHEZZI, P. ANNOVAZZI, S. BALDINI, A. BIANCHI, M. ZAFFARONI, G. MINONZIO, G. COMI (Milano, Gallarate - VA) 144. BREASTFEEDING AND RISK OF MULTIPLE SCLEROSIS IN TWO DISTINCT POPULATIONS: ITALY AND NORWAY G. RAGNEDDA, S. LEONI, I. CASETTA, M. PARPINEL, T. RIISE, J. DRULOVIC, E. GRANIERI, T. HOLMØY, M. KAMPMAN, A. LANDTBLOM, K. MYHR, T. PEKMEZOVIC, C. WOLFSON, M. PUGLIATTI (Sassari, Ferrara, U<strong>di</strong>ne, Bergen - N, Belgrado - SRB, Oslo - N, Tromsø - N, Linköping - S, Montreal - CDN) 145. ITALIAN VERSION OF MINIMAL ASSESSMENT OF COGNITIVE FUNCTION IN MULTIPLE SCLEROSIS IN RELAPSING-REMITTING AND PROGRESSIVE MULTIPLE SCLEROSIS PATIENTS A. GHAZARYAN, S. MIGLIORE, D. LANDI, F. MOFFA, M. PALMIERI, F. VERNIERI, P. PASQUALETTI, M. FILIPPI (Roma) 146. THE AUTONOMIC BALANCE PREDICTS CARDIAC EFFECTS AFTER FIRST DOSE OF FINGOLIMOD S. ROSSI, C. ROCCHI, C. MOTTA, B. LAURETTI, V. STUDER, F. MONTELEONE, G. GERMANI, F. BARBIERI, G. MACCHIARULO, G. MARFIA, D. CENTONZE (Roma) 147. OPTIC NERVE INVOLVEMENT IN A MODEL OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS RAT IMMUNIZED BY SPINAL CORD HOMOGENATE R. SANTANGELO, V. CASTOLDI, M. CAMBIAGHI, L. CAMALEONTI, E. CAPITOLO, M. CURSI, G. DINA, G. COMI, L. CHAABANE, A. QUATTRINI, L. LEOCANI (Milano) 148. MEASURING THE QUALITY OF MULTIPLE SCLEROSIS DIAGNOSIS COMMUNICATION: COSM-S, A REFINEMENT OF COSM-R SCALE THROUGH RASCH ANALYSIS A. SOLARI, M. GRZEDA, A. GIORDANO, A. SIMONE, L. VIGNATELLI, K. MATTAROZZI, R. D’ALESSANDRO, L. TESIO, ON BEHALF OF THE AGORÀ , GERONIMUS, SIMS- TRIAL AND SIMS-PRACTICE GROUPS (Milano, Warsaw - PL, Bologna) 149. EFFECTS OF MOTOR REHABILITATION ON CORPUS CALLOSUM MICROSTRUCTURAL INTEGRITY IN MULTIPLE SCLEROSIS L. BONZANO, M. BOVE, A. TACCHINO, G. BRICHETTO, L. ROCCATAGLIATA, P. FERACO, M. BATTAGLIA, G. MANCARDI (Genova) 138
150. CEREBROSPINAL FLUID CXCL13 AS A PROGNOSTIC MARKER IN CLINICALLY ISOLATED SYNDROME PATIENTS D. FERRARO, L. FEDERZONI, V. GALLI, R. BEDIN, F. VITETTA, A. SIMONE, P. NICHELLI, P. SOLA (Modena) 151. UNMET NEEDS OF PEOPLE WITH SEVERE MULTIPLE SCLEROSIS AND THEIR CARERS: QUALITATIVE DATA TO CONSTRUCT A HOME PALLIATIVE CARE PROGRAM A. SOLARI, C. BORREANI, E. BIANCHI, S. CILIA, M. GIUNTOLI, E. PIETROLONGO, I. ROSSI, M. GRASSO, F. PATTI, L. LOPES, A. LUGARESI, P. CONFALONIERI, P. MORINO, L. PALMISANO, G. MARTINO, M. PONZIO, R. AMADEO, P. ZARATIN, M. BATTAGLIA, A. GIORDANO, A. SOLARI ON BEHALF OF THEPENSAMI PROJECT (Milano, Catania, Genova, Chieti, Roma, Firenze) 152. CEREBELLAR FUNCTIONAL CONNECTIVITY IN PATIENTS WITH PEDIATRIC MULTIPLE SCLEROSIS S. CIRILLO, M. ROCCA, P. VALSASINA, P. VEGGIOTTI, L. MOIOLA, A. GHEZZI, G. COMI, A. FALINI, M. FILIPPI (Milano, Pavia, Gallarate - VA) 153. EFFECTS OF GLATIRAMER ACETATE ON CORTICAL FUNCTIONS AND FATIGUE IN MULTIPLE SCLEROSIS: A MORPHO-FUNCTIONAL MRI STUDY P. TORTORELLA, L. GRIFFANTI, F. BAGLIO, M. CABINIO, P. CECCONI, D. CAPUTO, M. ROVARIS (Milano) 154. PREVALENCE OF AUTOIMMUNE THYROIDITIS IN AN ITALIAN MULTIPLE SCLEROSIS COHORT S. MONTELLA, I. CERILLO, G. CERULLO, M. PETRACCA, N. OREFICE, D. ARPAIA, B. BIONDI, G. OREFICE, P. CARRIERI (Napoli) 155. PREVALENCE AND PROFILES OF COGNITIVE IMPAIRMENT IN PATIENTS WITH CLINICALLY ISOLATED SYNDROMES, RELAPSING AND PROGRESSIVE MULTIPLE SCLEROSIS E. PORTACCIO, B. GORETTI, B. HAKIKI, F. PATTI, S. CILIA, P. GALLO, P. GROSSI, R. VITERBO, A. GHEZZI, M. ROSCIO, F. MATTIOLI, C. STAMPATORI, M. TROJANO, M. AMATO (Firenze, Catania, Padova, Bari, Gallarate - VA, Brescia) 156. “REBOUND” ACTIVITY AFTER NATALIZUMAB AND FINGOLIMOD TREATMENT INTERRUMPTION M. RADAELLI, L. MOIOLA, F. SANGALLI, V. BARCELLA, L. FERRÈ, M. RODEGHER, G. COMI, V. MARTINELLI (Milano) 157. RITUXIMAB TREATMENT IN PATIENTS AFFECTED BY NEUROMYELITIS OPTICA SPECTRUM OF DISORDER: LONG TERM SAFETY AND EFFICACY IN CLINICAL PRACTICE M. RADAELLI, L. MOIOLA, M. RODEGHER, B. COLOMBO, R. FAZIO, F. SANGALLI, V. BARCELLA, L. FERRÈ, P. PREZIOSA, V. MARTINELLI, G. COMI (Milano) 158. AN OBSERVATIONAL STUDY OF FINGOLIMOD TREATED RELAPSING MS PATIENTS: EARLY DATA ON SAFETY AND EFFICACY D. PAOLICELLI, A. MANNI, V. DIRENZO, M. D’ONGHIA, M. RUGGIERI, M. TROJANO (Bari) 159. RELATION BETWEEN DISEASE DURATION, DISABILITY AND COGNITIVE IMPAIRMENT IN MULTIPLE SCLEROSIS G. FENU, E. COCCO, L. LOREFICE, M. MURGIA, C. SARDU, G. COGHE, J. FRAU, M. MELIS, L. MUSU, M. MARROSU (Cagliari) 160. WII MAY IMPROVE PHYSICAL ABILITIES IN MULTIPLE SCLEROSIS: A RANDOMIZED SINGLE BLIND STUDY C. LEONE, V. CIMINO, V. DIBILIO, S. MESSINA, E. D’AMICO, C. CHISARI, A. RUSSO, D. VECA, F. ZAGARI, F. PATTI, M. ZAPPIA (Catania) 3 N O V E M B R E • A R E A P O S T E R 139
Page 1:
2 5
Page 7 and 8:
Sotto l’Alto Patronato della Pres
Page 9 and 10:
CONSIGLIO DIRETTIVO SIN Presidente
Page 11 and 12:
IN TRENO Stazione Centrale - Stazio
Page 13:
Accademia Nazionale di Medicina 16
Page 16 and 17:
AUDITORIUM SALA SILVER 12.30 - 13.3
Page 18 and 19:
2 N O V E M B R E • S A L A G I A
Page 20 and 21:
2 N O V E M B R E • S A L A CORSO
Page 22 and 23:
Page 24 and 25:
2 N O V E M B R E • CORSO A.N.I.N
Page 26 and 27:
2 N O V E M B R E • S A L A SIMPO
Page 28 and 29:
2 N O V E M B R E • S A L A B L U
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
DOMENICA 3 NOVEMBRE AUDITORIUM SALA
Page 36 and 37:
3 N O V E M B R E • A U D I T O R
Page 38 and 39:
Page 40 and 41:
3 N O V E M B R E • S A L A R O S
Page 42 and 43:
3 N O V E M B R E • COMUNICAZIONI
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
3 N O V E M B R E • S A L A B I A
Page 50 and 51:
3 N O V E M B R E • S A L A RIUNI
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
3 N O V E M B R E • S A L A WORKS
Page 60 and 61:
Page 62 and 63:
3 N O V E M B R E • S A L A WORKS
Page 64 and 65:
Page 66 and 67:
LUNEDI 4 NOVEMBRE AUDITORIUM SALA S
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
4 N O V E M B R E • COMUNICAZIONI
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
4 N O V E M B R E • LETTURA ore 1
Page 86 and 87:
Page 88 and 89:
Page 90 and 91: 4 N O V E M B R E • A U D I T O R
Page 92 and 93: 4 N O V E M B R E • S A L A R O S
Page 94 and 95: 4 N O V E M B R E • S A L A B L U
Page 96 and 97: 4 N O V E M B R E • S A L A WORKS
Page 100 and 101: MARTEDI 5 NOVEMBRE AUDITORIUM SALA
Page 102 and 103: 5 N O V E M B R E • S A L A BREAK
Page 104 and 105: 5 N O V E M B R E • S A L A B I A
Page 106 and 107: 5 N O V E M B R E • S A L A R O S
Page 108 and 109: 5 N O V E M B R E • S A L A B L U
Page 110 and 111: 5 N O V E M B R E • S A L A G I A
Page 114 and 115: 5 N O V E M B R E • S A L A T U R
Page 116 and 117: 5 N O V E M B R E • S A L A TRIAL
Page 124 and 125: 5 N O V E M B R E • S A L A B I A
Page 126 and 127: 5 N O V E M B R E • CHIUSURA DEI
Page 128 and 129: 3 N O V E M B R E • A R E A P O S
Page 152 and 153: 150
Page 190 and 191:
5 N O V E M B R E • A R E A P O S
Page 192 and 193:
Page 194 and 195:
5 N O V E M B R E • A R E A 754.
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
SEGRETERIA IN SEDE CONGRESSUALE La
Page 202 and 203:
ACCREDITAMENTO ECM La Commissione N
Page 204 and 205:
CERTIFICATO ECM Fin quando non era
Page 207 and 208:
Si ringraziano, per l’indispensab
Page 209 and 210:
SI RINGRAZIANO PER LA PARTECIPAZION
Page 212:
SEGRETERIA ORGANIZZATIVA SIN Studio
show all

programma definitivo - SocietÃ italiana di neurologia

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?